Natixis Advisors’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $630K | Buy |
+34,362
| New | +$653K | ﹤0.01% | 1490 |
|
|
2025
Q4 | – | Sell |
-11,666
| Closed | -$226K | – | 1593 |
|
|
2025
Q3 | $226K | Sell |
11,666
-2,216
| -16% | -$43.3K | ﹤0.01% | 1615 |
|
|
2025
Q2 | $287K | Sell |
13,882
-2,860
| -17% | -$59.5K | ﹤0.01% | 1549 |
|
|
2025
Q1 | $410K | Buy |
+16,742
| New | +$430K | ﹤0.01% | 1496 |
|
|
2024
Q4 | – | Sell |
-228,234
| Closed | -$9.67M | – | 1608 |
|
|
2024
Q3 | $9.67M | Buy |
228,234
+40,174
| +21% | +$2.11M | 0.02% | 661 |
|
|
2024
Q2 | $9.63M | Buy |
188,060
+177,445
| +1,672% | +$10.1M | 0.02% | 617 |
|
|
2024
Q1 | $664K | Buy |
+10,615
| New | +$722K | ﹤0.01% | 1327 |
|
|
2023
Q4 | – | Sell |
-51,231
| Closed | -$4.36M | – | 1520 |
|
|
2023
Q3 | $4.36M | Sell |
51,231
-3,971
| -7% | -$377K | 0.01% | 753 |
|
|
2023
Q2 | $6.02M | Buy |
55,202
+32,764
| +146% | +$3.11M | 0.02% | 658 |
|
|
2023
Q1 | $1.86M | Sell |
22,438
-8,448
| -27% | -$795K | 0.01% | 972 |
|
|
2022
Q4 | $3.17M | Buy |
30,886
+3,907
| +14% | +$450K | 0.01% | 809 |
|
|
2022
Q3 | $2.86M | Sell |
26,979
-4,700
| -15% | -$515K | 0.01% | 788 |
|
|
2022
Q2 | $3.48M | Buy |
31,679
+6,868
| +28% | +$680K | 0.02% | 754 |
|
|
2022
Q1 | $2.59M | Sell |
24,811
-3,913
| -14% | -$406K | 0.01% | 887 |
|
|
2021
Q4 | $3.51M | Sell |
28,724
-8
| -0% | -$888 | 0.01% | 794 |
|
|
2021
Q3 | $3.3M | Buy |
28,732
+1,799
| +7% | +$191K | 0.01% | 772 |
|
|
2021
Q2 | $2.61M | Sell |
26,933
-836
| -3% | -$72.5K | 0.01% | 828 |
|
|
2021
Q1 | $2.05M | Sell |
27,769
-31,348
| -53% | -$2.33M | 0.01% | 867 |
|
|
2020
Q4 | $4.04M | Sell |
59,117
-38,301
| -39% | -$2.5M | 0.02% | 635 |
|
|
2020
Q3 | $5.7M | Sell |
97,418
-241
| -0.2% | -$12.7K | 0.04% | 481 |
|
|
2020
Q2 | $4.42M | Sell |
97,659
-3,766
| -4% | -$180K | 0.03% | 554 |
|
|
2020
Q1 | $5.86M | Sell |
101,425
-24,957
| -20% | -$1.71M | 0.05% | 410 |
|
|
2019
Q4 | $7.88M | Buy |
126,382
+1,822
| +1% | +$108K | 0.06% | 386 |
|
|
2019
Q3 | $7.17M | Sell |
124,560
-527
| -0.4% | -$29.2K | 0.06% | 360 |
|
|
2019
Q2 | $6.79M | Buy |
125,087
+5,285
| +4% | +$268K | 0.06% | 373 |
|
|
2019
Q1 | $5.64M | Buy |
119,802
+16,657
| +16% | +$923K | 0.05% | 412 |
|
|
2018
Q4 | $5.84M | Buy |
103,145
+8,809
| +9% | +$494K | 0.06% | 362 |
|
|
2018
Q3 | $5.16M | Buy |
94,336
+11,212
| +13% | +$642K | 0.05% | 450 |
|
|
2018
Q2 | $4.87M | Buy |
83,124
+29,748
| +56% | +$1.78M | 0.05% | 466 |
|
|
2018
Q1 | $3.03M | Sell |
53,376
-26,172
| -33% | -$1.42M | 0.03% | 624 |
|
|
2017
Q4 | $3.92M | Sell |
79,548
-50,637
| -39% | -$2.31M | 0.04% | 497 |
|
|
2017
Q3 | $5.95M | Sell |
130,185
-1,029
| -0.8% | -$39.3K | 0.06% | 375 |
|
|
2017
Q2 | $5.12M | Buy |
131,214
+5,918
| +5% | +$227K | 0.06% | 417 |
|
|
2017
Q1 | $5.09M | Buy |
125,296
+45,096
| +56% | +$1.77M | 0.06% | 421 |
|
|
2016
Q4 | $3.08M | Buy |
+80,200
| New | +$2.74M | 0.04% | 554 |
|
Other funds holding AMN
VCM
VPM
Natixis Advisors's AMN Position: Q1 2026 in Review
Natixis Advisors opened a new position in AMN Healthcare (AMN) in Q1 2026: 34,362 shares worth $630K. The stake represents ﹤0.01% of the portfolio and ranks #1490 among its holdings. This is a return to the name: Natixis Advisors previously reported a position in AMN as recently as Q3 2025.
Natixis Advisors first reported a position in AMN in Q4 2016 and has held it in 35 quarters since. The position peaked at $9.67M in Q3 2024. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.
- Natixis Advisors held 34,362 shares of AMN Healthcare worth $630K as of Q1 2026.
- AMN Healthcare was a new Natixis Advisors position in Q1 2026.
- AMN Healthcare made up ﹤0.01% of Natixis Advisors's portfolio in Q1 2026, its #1490 holding.
- Natixis Advisors first reported a position in AMN Healthcare in Q4 2016 and has held it in 35 quarters since.
- Natixis Advisors's AMN Healthcare position peaked at $9.67M in Q3 2024.
- 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.
Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.